C12Y 204/01174
Glucuronylgalactosylproteoglycan 4-beta-n-acetylgalactosaminyltransferase , i.e. chondroitin sulfate n-acetylgalactosaminyltransferase-1
Official title: Glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase (2.4.1.174), i.e. chondroitin sulfate N-acetylgalactosaminyltransferase-1
C12Y204/01174 (Glucuronylgalactosylproteoglycan 4-beta-n-acetylgalactosaminyltransferase , i.e. chondroitin sulfate n-acetylgalactosaminyltransferase-1) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 4
- Assignees
- 5
- Inventors
- 16
- Latest grant
- 25 Oct 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Antisense nucleic acid capable of inhibiting biosynthesis of chondroitin sulfate10 Jul 2025US 2025/0223596 A1Aichi Medical University
- Antisense nucleic acid for inhibiting biosynthesis of chondroitin8 Apr 2021US 2021/0102214 A1Aichi Medical University
- Chondroitin sulfate synthesis promoter30 Jul 2009US 2009/0191176 A1Seikagaku Corporation
- Chondroitin sulfate synthesis promoter30 Aug 2007US 2007/0203087 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.